UDP‐Glucose‐6‐Dehydrogenase Mediated O‐GlcNAcylation of Tight Junction Protein 1 Suppresses Metastasis in Renal Cell Carcinoma
Advanced Science · 2026
DOI: 10.1002/advs.202522640 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Xiaolin Chen und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Peking University First Hospital, Beijing, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Uridine Diphosphate Glucose Dehydrogenase. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Noncommunicable Chronic Disease-National Science and Technology Major Project, National High Level Hospital Clinical Research Funding, National Natural Science Foundation of China.
Abstract (Originalsprache)
Tumor metastasis remains the leading cause of postoperative recurrence and mortality in patients with clear cell renal cell carcinoma (ccRCC). Although aberrant glucuronic acid metabolism and O‐GlcNAcylation are closely associated with tumor progression, the mechanism by which these pathways intersect to regulate ccRCC metastasis remains poorly understood. Here, an orthotopic ccRCC mouse model coupled with comparative proteomic analysis of primary and metastatic lesions identified UDP‐glucose‐6‐dehydrogenase (UGDH) as a pivotal suppressor of metastasis in ccRCC. In vitro and in vivo functional assays confirmed that UGDH overexpression markedly suppressed the invasion and migration of ccRCC cells. Mechanistically, we demonstrated that the E3 ubiquitin ligase TRIM25 facilitates UGDH degradation via K48‐linked polyubiquitination, whereas UGDH modulates the expression of tight junction protein 1 (TJP1) via O‐GlcNAcylation. Notably, pharmacological inhibition of O‐GlcNAcylation with OSMI‐1 effectively impeded metastasis in both cellular and animal models. This study reveals a novel tumor‐suppressive role for UGDH and highlights the potential of the TRIM25–UGDH–TJP1 axis for diagnostic and therapeutic strategies in metastatic ccRCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Peking University First Hospital, Beijing, China.
- Institute of Urology, Peking University, Beijing, China.
- Beijing Key Laboratory of Precision Medicine and Innovative Translation for Urogenital Diseases, Beijing, China.
- National Urological Cancer Center, Beijing, China.
- National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
- Laboratory Animal Center, Peking University First Hospital, Beijing, China.
ORCID-Profile: Kan Gong
Förderung
- Noncommunicable Chronic Disease-National Science and Technology Major Project
- National High Level Hospital Clinical Research Funding
- National Natural Science Foundation of China
Zitieren
APA
Chen, X., Bao, Y., Liu, T., Qiu, J., Ma, Y., Zhang, Z., Wang, C., Deng, R., Song, Z., He, T., Liu, H., Zhou, J., Wang, Y., & Gong, K. (2026). UDP‐Glucose‐6‐Dehydrogenase Mediated O‐GlcNAcylation of Tight Junction Protein 1 Suppresses Metastasis in Renal Cell Carcinoma. Advanced Science. https://doi.org/10.1002/advs.202522640
Vancouver
Chen X, Bao Y, Liu T, Qiu J, Ma Y, Zhang Z, et al. UDP‐Glucose‐6‐Dehydrogenase Mediated O‐GlcNAcylation of Tight Junction Protein 1 Suppresses Metastasis in Renal Cell Carcinoma. Advanced Science. 2026. doi:10.1002/advs.202522640
BibTeX
@article{Chen2026,
author = {Chen, Xiaolin and Bao, Yuhang and Liu, Tao and Qiu, Jianhui and Ma, Yuanyuan and Zhang, Zedan and Wang, Chuandong and Deng, Ruiyi and Song, Zheng and He, Tianyi and Liu, Haode and Zhou, Jingcheng and Wang, Yizhou and Gong, Kan},
title = {UDP‐Glucose‐6‐Dehydrogenase Mediated O‐GlcNAcylation of Tight Junction Protein 1 Suppresses Metastasis in Renal Cell Carcinoma},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202522640}
}
EUVIMED